Bempedoic acid (Nilemdo®▼) and Bempedoic acid / ezetimibe (Nustendi®▼) SMC card

Daiichi Sankyo logo

The production of this Guidelines card has been commissioned and funded by Daiichi Sankyo UK.

View Bempedoic acid (Nilemdo®) & Bempedoic acid and ezetimibe (Nustendi®) prescribing and adverse event reporting information

BEM/21/0831
Date of preparation: December 2021

Content for healthcare professionals

Access to this content is restricted to UK-based doctors, nurses, and pharmacists

If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one. 

Return to homepage